A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker.
Immunotherapy
; 8(9): 1011-9, 2016 09.
Article
in En
| MEDLINE
| ID: mdl-27485075
Full text:
1
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
B7-H1 Antigen
/
Antibodies, Monoclonal
/
Antineoplastic Agents
Type of study:
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Immunotherapy
Journal subject:
ALERGIA E IMUNOLOGIA
/
TERAPEUTICA
Year:
2016
Type:
Article
Affiliation country:
Brazil